Abstract
D
infants is mandatory before complications occur that prohibit the administration of anti-prostaglandin agent of similar efficacy, but fewer is more costly and less widely available than ibuprofen. Until now, there have been few reports on the comparative efficacy of these two agents in current standard of treatment for persistent ductus is indomethacin.
The aims of this study were to compare the efficacy of ibuprofen and indomethacin in preterm DA closure for each intervention.
Methods
A randomized double-blind controlled trial was conducted in the Department of Neonatology, the in Nursery in the Department of Child Health at mm 3 , ductal-dependent congenital heart disease, major congenital anomalies, necrotizing enterocolitis, confirmed by echocardiography using a Philips® HD7 XE into two groups by consecutive sampling, either the The parameters of treatment response were DA closure and diameter reduction, taken in serial measurements. Ductus arteriosus reopening was defined as a DA that reopened after closure, as determined by echocardiographic evaluation after three doses of oral ibuprofen or indomethacin administration.
Ductus arteriosus monitoring was performed diuresis was monitored daily. Subjects were considered to have dropped out of bleeding, gastrointestinal perforation, necrotizing enterocolitis, or decreased renal function in the first to third days of medication administration.
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level. Differences between groups were analyzed by student's T-test. Differences in proportions between
Chi-square tests. Survival rate was analyzed with Kaplan-Meier test.
Results
were enrolled in this study. Subjects were divided the indomethacin group. The basic characteristics of subjects are shown in Table 1 . Four infants in the ibuprofen group and four in the indomethacin group dropped out due to pulmonary Table  2a, Table 2b Unpaired T-test was also performed to compare DA constriction after three doses of oral ibuprofen and indomethacin. Similarly, there was a significant found no significant difference in mean days to closure shown in Table 3a and Table 3b .
One infant in the indomethacin group had Table 2a was monitored before and after therapy for both groups. We found no significant difference in the There was significantly higher creatinine serum elevation after indomethacin administration com- As shown in Figure 1 , the consort diagram of failed to respond to treatment in the ibuprofen group the indomethacin group, but none occurred in the ibuprofen group. indomethacin group, while none reopened in the ibuprofen group. Similarly, Heyman et al. reported no DA reopening in the ibuprofen group. 6 et al. reported that the incidence rate of DA reopening after Reopening may be caused by pulmonary disorders. The mechanism involved response of DA to subjects were pneumonia, hyaline membrane disease, and transient tachypnea of the newborn.
Discussion
A limitation of this study was the occurrence of complications, such as septicemia, hyaline membrane difficult to monitor patients for long periods due to the high incidence of morbidity and mortality. the intervention or complication, often occurs in premature infants.
in the closure of DA after ibuprofen administration compared to that of indomethacin. Also, DA diameter reduction is significantly greater after ibuprofen administration compares to that of indomethacin. There is also a significantly higher serum creatinine elevation after indomethacin administration compares to that of ibuprofen. 
